BBCMF (Lir Life Sciences) Research & Development: $0.01 Mil (TTM As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Research & Development?

Lir Life Sciences BBCMF -80.00% 15 Research & Development is $0.01 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Research & Development is the aggregate amount of research and development expenses during the year. Lir Life Sciences's Research & Development for the three months ended in Jan. 2026 was $0.01 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was $0.01 Mil.

Lir Life Sciences  (OTCPK:BBCMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lir Life Sciences Research & Development Related Terms

Lir Life Sciences Research & Development Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Research & Development Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Research & Development
0.00 0.00

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.01
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.01 Mil mean?
Lir Life Sciences (BBCMF) has a Research & Development of $0.01 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Research & Development too high?
Lir Life Sciences' current Research & Development is $0.01 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Research & Development compare to VRTX and REGN?
Lir Life Sciences' Research & Development of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Research & Development is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Research & Development of $0.01 Mil. The current Research & Development is $0.01 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Research & Development is $0.01 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price